Opus Genetics outlines five gene therapy programs for retinal diseases
Go back to Opus Genetics outlines five gene therapy programs for retinal diseases| Diversified Corporate Resources, Inc. (NASDAQ: IRD) | Delayed: 3.69 -0.16 (4.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.85 | 52 Week High | $0.02 | |||
| Open | $3.85 | 52 Week Low | $0.02 | |||
| Day High | $3.86 | P/E | N/A | |||
| Day Low | $3.63 | EPS | $0.00 | |||
| Volume | 823,628 | |||||
